Should I buy or sell Clover Health Investments stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CLOV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares. View CLOV analyst ratings or view top-rated stocks .

What is Clover Health Investments' stock price target for 2024?

1 Wall Street research analysts have issued 12 month price targets for Clover Health Investments' stock. Their CLOV share price targets range from $1.50 to $1.50. On average, they expect the company's stock price to reach $1.50 in the next twelve months. This suggests a possible upside of 137.7% from the stock's current price. View analysts price targets for CLOV or view top-rated stocks among Wall Street analysts .

How have CLOV shares performed in 2024?

Clover Health Investments' stock was trading at $0.9521 at the beginning of the year. Since then, CLOV shares have decreased by 33.7% and is now trading at $0.6311. View the best growth stocks for 2024 here .

Are investors shorting Clover Health Investments?

Clover Health Investments saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 43,980,000 shares, a decrease of 7.5% from the March 15th total of 47,540,000 shares. Based on an average daily volume of 9,360,000 shares, the short-interest ratio is currently 4.7 days. View Clover Health Investments' Short Interest .

When is Clover Health Investments' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our CLOV earnings forecast .

How were Clover Health Investments' earnings last quarter?

Clover Health Investments, Corp. (NASDAQ:CLOV) announced its quarterly earnings data on Tuesday, March, 12th. The company reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.18) by $0.06. The company had revenue of $510.25 million for the quarter, compared to the consensus estimate of $491.20 million. Clover Health Investments had a negative trailing twelve-month return on equity of 62.58% and a negative net margin of 10.49%.

Who are Clover Health Investments' major shareholders?

Clover Health Investments' stock is owned by a number of institutional and retail investors. Top institutional investors include SignalPoint Asset Management LLC (0.03%) and Allspring Global Investments Holdings LLC (0.02%). Insiders that own company stock include Anna U Loengard, Chamath Palihapitiya , Chelsea Clinton and Lee Shapiro. View institutional ownership trends .

How do I buy shares of Clover Health Investments?

Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Positive News SentimentPositive News

NASDAQ:CLOV

Clover Health Investments (CLOV) Stock Price, News & Analysis

→ The Next Nvidia? (From InvestorPlace) (Ad)

Free CLOV Stock Alerts

$0.63

+0.01 (+1.61%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.62
▼
$0.65
50-Day Range: $0.62
▼
$1.02
52-Week Range: $0.61
▼
$1.63

Volume: 2.86 million shs
Average Volume: 9.11 million shs
Market Capitalization: $312.58 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $1.50

Get Clover Health Investments alerts:

Clover Health Investments MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 137.7% Upside
$1.50 Price Target
Short Interest: Healthy
8.88% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Acquiring Shares
$100,010 Bought Last Quarter
Proj. Earnings Growth: Growing
From ($0.20) to ($0.16) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.35 out of 5 stars

Medical Sector

496th out of 918 stocks

Hospital & Medical Service Plans Industry

9th out of 11 stocks

3.0

Analyst's Opinion

Consensus Rating
Clover Health Investments has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
Clover Health Investments has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
8.88% of the outstanding shares of Clover Health Investments have been sold short.
Short Interest Ratio / Days to Cover
Clover Health Investments has a short interest ratio ("days to cover") of 4.7.
Change versus previous month
Short interest in Clover Health Investments has recently decreased by 7.49%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Clover Health Investments does not currently pay a dividend.
Dividend Growth
Clover Health Investments does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CLOV.

2.5

News and Social Media Coverage

News Sentiment
Clover Health Investments has a news sentiment score of 1.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Clover Health Investments this week, compared to 2 articles on an average week.
Search Interest
Only 24 people have searched for CLOV on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
MarketBeat Follows
Only 13 people have added Clover Health Investments to their MarketBeat watchlist in the last 30 days. This is a decrease of -32% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Clover Health Investments insiders have bought more of their company's stock than they have sold. Specifically, they have bought $100,010.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
21.82% of the stock of Clover Health Investments is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 19.77% of the stock of Clover Health Investments is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Clover Health Investments are expected to grow in the coming year, from ($0.20) to ($0.16) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Clover Health Investments is -1.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Clover Health Investments is -1.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Clover Health Investments has a P/B Ratio of 1.07. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Clover Health Investments Stock (NASDAQ:CLOV)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

CLOV Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CLOV Stock News Headlines

March 19, 2024 | insidertrades.com

Clover Health Investments, Corp. (NASDAQ:CLOV) Director Acquires $100,010.00 in Stock

April 9, 2024 | msn.com

The 26 Best Gym Bags For Your Workout Essentials

April 18, 2024 | InvestorPlace (Ad)

The Next Nvidia?

The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.

April 6, 2024 | uk.investing.com

Clover Health settles shareholder lawsuits, enhances governance

April 4, 2024 | globenewswire.com

Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions

April 4, 2024 | msn.com

JMP starts HealthEquity at market outperform, cites revenue growth

March 21, 2024 | markets.businessinsider.com

Cautious Optimism on Clover Health’s Performance with Concerns on Long-Term Profitability

March 20, 2024 | finance.yahoo.com

Insider Spends US$110k Buying More Shares In Clover Health Investments

April 18, 2024 | InvestorPlace (Ad)

The Next Nvidia?

March 20, 2024 | investorplace.com

3 Under-the-Radar Stocks to Transform $10K into $100K by 2028

March 19, 2024 | globenewswire.com

Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness

March 18, 2024 | finance.yahoo.com

Downgrade: Here's How Analysts See Clover Health Investments, Corp. (NASDAQ:CLOV) Performing In The Near Term

March 15, 2024 | finance.yahoo.com

CLOV Mar 2024 2.000 call

March 15, 2024 | benzinga.com

Peering Into Clover Health Investments's Recent Short Interest

March 15, 2024 | ca.finance.yahoo.com

CLOV Mar 2024 2.000 put

March 14, 2024 | seekingalpha.com

Clover Health Investments, Corp. (CLOV) Q4 2023 Earnings Call Transcript

March 14, 2024 | finance.yahoo.com

Clover Health Investments Full Year 2023 Earnings: Beats Expectations

March 13, 2024 | finance.yahoo.com

Clover Health Investments, Corp. (NASDAQ:CLOV) Q4 2023 Earnings Call Transcript

March 13, 2024 | uk.style.yahoo.com

27 show home tricks and how to spot them

March 13, 2024 | markets.businessinsider.com

Clover Health Investments: Hold Rating with High Risk Amidst Progress Towards Stability

March 13, 2024 | finance.yahoo.com

Q4 2023 Clover Health Investments Corp Earnings Call

March 12, 2024 | globenewswire.com

Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance

March 11, 2024 | msn.com

Clover Health Q4 2023 Earnings Preview

March 11, 2024 | benzinga.com

Clover Health Investments's Earnings Outlook

March 11, 2024 | markets.businessinsider.com

Clover Health Investments A earnings: here's what Wall Street expects

March 10, 2024 | finance.yahoo.com

CLOV Mar 2024 0.500 call

March 9, 2024 | finance.yahoo.com

CLOV Mar 2024 0.500 put

See More Headlines

Receive CLOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/12/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/14/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Hospital & medical service plans
Sub-Industry: N/A
Current Symbol: NASDAQ:CLOV
CUSIP: N/A
CIK: 1801170
Web: www.cloverhealth.com
Phone: 201-432-2133
Fax: N/A
Employees: 552
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $1.50
High Stock Price Target: $1.50
Low Stock Price Target: $1.50
Potential Upside/Downside: +137.7%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.45)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-213,360,000.00
Net Margins: -10.49%
Pretax Margin: -10.49%
Return on Equity: -62.58%
Return on Assets: -18.19%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.64
Quick Ratio: 1.64

Sales & Book Value

Annual Sales: $2.03 billion
Price / Sales: 0.15
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.59 per share
Price / Book: 1.07

Miscellaneous

Outstanding Shares: 495,290,000
Free Float: 387,219,000
Market Cap: $312.58 million
Optionable: Optionable
Beta: 1.84

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Vivek Garipalli (Age 45)
Co-Founder & Executive Chairman
Mr. Andrew Toy (Age 45)
Co-Founder, CEO & Director
Comp: $1.01M
Mr. Brady Priest J.D. (Age 47)
Chief Executive Officer of Home Care
Comp: $587.36k
Mr. Terrence Ronan (Age 64)
Interim CFO, Principal Financial Officer & Principal Accounting Officer
Mr. Conrad Wai (Age 43)
Chief Technology Officer
Mr. Derrick L. Nueman
Head of Investor Relations & Corporate strategy
Ms. Wendy Richey
Chief Compliance Officer
Ms. Karen Soares
General Counsel, Senior VP & Corporate Secretary
Ms. Rachel Fish
Chief People Officer
Ms. Jamie L. Reynoso (Age 54)
Chief Executive Officer of Medicare Advantage
Comp: $461.74k

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CLOV Stock Analysis - Frequently Asked Questions

Should I buy or sell Clover Health Investments stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CLOV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares.
View CLOV analyst ratings or view top-rated stocks.
What is Clover Health Investments' stock price target for 2024?: 1 Wall Street research analysts have issued 12 month price targets for Clover Health Investments' stock. Their CLOV share price targets range from $1.50 to $1.50. On average, they expect the company's stock price to reach $1.50 in the next twelve months. This suggests a possible upside of 137.7% from the stock's current price.
View analysts price targets for CLOV or view top-rated stocks among Wall Street analysts.
How have CLOV shares performed in 2024?: Clover Health Investments' stock was trading at $0.9521 at the beginning of the year. Since then, CLOV shares have decreased by 33.7% and is now trading at $0.6311.
View the best growth stocks for 2024 here.
Are investors shorting Clover Health Investments?: Clover Health Investments saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 43,980,000 shares, a decrease of 7.5% from the March 15th total of 47,540,000 shares. Based on an average daily volume of 9,360,000 shares, the short-interest ratio is currently 4.7 days.
View Clover Health Investments' Short Interest.

When is Clover Health Investments' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our CLOV earnings forecast.
How were Clover Health Investments' earnings last quarter?: Clover Health Investments, Corp. (NASDAQ:CLOV) announced its quarterly earnings data on Tuesday, March, 12th. The company reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.18) by $0.06. The company had revenue of $510.25 million for the quarter, compared to the consensus estimate of $491.20 million. Clover Health Investments had a negative trailing twelve-month return on equity of 62.58% and a negative net margin of 10.49%.
Who are Clover Health Investments' major shareholders?: Clover Health Investments' stock is owned by a number of institutional and retail investors. Top institutional investors include SignalPoint Asset Management LLC (0.03%) and Allspring Global Investments Holdings LLC (0.02%). Insiders that own company stock include Anna U Loengard, Chamath Palihapitiya, Chelsea Clinton and Lee Shapiro.
View institutional ownership trends.
How do I buy shares of Clover Health Investments?: Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CLOV) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial